Terbium-161 PSMA Therapy Delivers High Tumor Doses With Tolerable Organ Exposure
The largest dosimetry study of terbium-161 PSMA-617 radioligand therapy shows high tumor-absorbed doses with tolerable organ exposure in prostate cancer ...
The largest dosimetry study of terbium-161 PSMA-617 radioligand therapy shows high tumor-absorbed doses with tolerable organ exposure in prostate cancer ...
A new cumulative cold-dose model could help clinicians plan cryoablation by combining lethal temperature, exposure time, tissue sensitivity and repeated ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine